paxilline has been researched along with atrial natriuretic factor in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Almeida, EA; Damsky, CH; Gardner, DG; Ilić, D; Kovacic-Milivojević, B; Roediger, F | 1 |
Chen, RJ; Ho, TJ; Huang, CY; Kumar, VB; Kuo, CH; Lin, KH; Padma, VV; Shanmugam, T; Shibu, MA; Yeh, YL | 1 |
2 other study(ies) available for paxilline and atrial natriuretic factor
Article | Year |
---|---|
Focal adhesion kinase and p130Cas mediate both sarcomeric organization and activation of genes associated with cardiac myocyte hypertrophy.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Cell Fractionation; Cells, Cultured; Crk-Associated Substrate Protein; Culture Media, Serum-Free; Cytoskeletal Proteins; Endothelins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation; Genes, Reporter; Immunoblotting; Immunohistochemistry; Microfilament Proteins; Myocardium; Myosin Heavy Chains; Paxillin; Phosphoproteins; Phosphorylation; Promoter Regions, Genetic; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Proteins; Rats; Recombinant Fusion Proteins; Retinoblastoma-Like Protein p130; Sarcomeres; Signal Transduction; src-Family Kinases; Tensins | 2001 |
miR-145-5p targets paxillin to attenuate angiotensin II-induced pathological cardiac hypertrophy via downregulation of Rac 1, pJNK, p-c-Jun, NFATc3, ANP and by Sirt-1 upregulation.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Gene Expression Regulation; MAP Kinase Kinase 4; MicroRNAs; Myoblasts, Cardiac; NFATC Transcription Factors; Paxillin; Proto-Oncogene Proteins c-jun; rac1 GTP-Binding Protein; Rats; Sirtuin 1; Vasoconstrictor Agents | 2021 |